ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "patient outcomes"

  • Abstract Number: 2846 • 2019 ACR/ARP Annual Meeting

    Outcomes over the First 5 Years of Follow up in a Very Early Rheumatoid Arthritis (RA) Cohort Recruited over 20 Years: Most of the Improvement Occurred Before the 2011 Implementation of Treat-to-Target (T2T)

    Nathalie Carrier 1, Sophie Roux 2, Ariel Masetto 2, Artur deBrum Fernandes 2, Patrick Liang 2, Meryem Maoui 3 and Gilles Boire2, 1CIUSSS de l'Estrie-CHUS, Sherbrooke, QC, Canada, 2Université de Sherbrooke, Sherbrooke, QC, Canada, 3Bristol-Myers Squibb Canada, St-Laurent, QC, Canada

    Background/Purpose: To analyze the evolution over 20 years of disease activity, treatments and radiographic progression over the first 5 years of follow up of patients…
  • Abstract Number: 438 • 2019 ACR/ARP Annual Meeting

    Longitudinal Construct Validity and Responsiveness of MDHAQ and HAQDI in PsA: Can MDHAQ Replace HAQDI?

    Marilyn Wan1, Jessica Walsh 2, M. Elaine Husni 3, Jose Scher 4, Soumya Reddy 5 and Alexis Ogdie 6, 1University of Pennsylvania, Philadelphia, 2Division of Rheumatology, University of Utah, Salt Lake City, UT, 3Department of Rheumatologic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, 4Division of Rheumatology, New York University School of Medicine and NYU Langone Orthopedic Hospital, New York, NY, 5Division of Rheumatology, New York University School of Medicine, New York, NY, 6Department of Medicine and Rheumatology and Department of Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

    Background/Purpose: The multi-dimensional health assessment questionnaire (MDHAQ) is a patient-reported outcome that is commonly used in clinical practice in the US and comprises of 10…
  • Abstract Number: 439 • 2019 ACR/ARP Annual Meeting

    Improved Patient-Reported Outcomes in Patients with Persistently Active Rheumatoid Arthritis Following Treatment with Repository Corticotropin Injection

    Daniel Furst1, George Wan 2, Jingyu Liu 3, Julie Zhu 3, Laura Bartels-Peculis 3, Mary Panaccio 3 and Roy Fleischmann 4, 1University of California, Los Angeles, CA, 2Mallinckrodt Pharmaceuticals, Bedminster, NJ, 3Mallinckrodt Pharmaceuticals, ARD, LLC, Bedminster, NJ, 4Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disorder characterized by progressive inflammation and irreversible joint damage. Treatment of active disease includes disease-modifying anti-rheumatic drugs (DMARDs)…
  • Abstract Number: 662 • 2019 ACR/ARP Annual Meeting

    Utility of a Mobile Phone Based Application to Collect Patient-Reported Outcome Information from People Living with Systemic Lupus Erythematosus

    Brooke Williams1, Bridget Muckian 1, Claire Dykas 2, Christine Peschken 3, Richard Furie 4, Elena Massarotti 5, Vanja sikirica 6, Steven Gilbert 7, Martin Hodge 7 and Peter Lipsky 8, 1AMPEL BioSolutions, Charlottesville, VA, 2AmpelBioSolutions, Charlottesville, VA, 3University of Manitoba, Winnepeg, Canada, 4Northwell Health, Great Neck, NY, 5Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 6Pfizer, Boston, MA, 7Pfizer, Boston, 8AMPEL BioSolutions, LLC, Charlottesville, VA

    Background/Purpose: Patient Reported Outcomes (PROs) can provide important data about the impact of a disease on an individual and/or the quality of the response to…
  • Abstract Number: 834 • 2019 ACR/ARP Annual Meeting

    Implementing Patient-Reported Outcome Measures in Clinical Care: Rheumatologist Perspectives on Opportunities and Challenges

    Shanthini Kasturi1, John Wong 1, Lisa Mandl 2, Timothy McAlindon 3 and Amy LeClair 1, 1Tufts Medical Center, Boston, 2Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, New York, NY, 3Tufts Medical Center, Boston, MA

    Background/Purpose: There is growing interest in the implementation of patient-reported outcome measures (PROMs) in clinical rheumatology to promote patient-centered care and to meet the mandates…
  • Abstract Number: 876 • 2019 ACR/ARP Annual Meeting

    “When You Read This, You Really Feel Old!” Perspectives of Young People with Inflammatory Arthritis on Patient Reported Outcome Measures from a European Qualitative Study

    Erika Mosor1, Paul Studenic 1, Alessia Alunno 2, Ivan Padjen 3, Wendy Olsder 4, Sofia Ramiro 5, Ilaria Bini 6, Nele Caeyers 7, Laure Gossec 8, Marios Kouloumas 9, Elena Nikiphorou 10, Simon Stones 11, Tanita Wilhelmer 12 and Tanja Stamm 1, 1Medical University of Vienna, Vienna, Austria, 2Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy, Perugia, Italy, 3UHC Zagreb and University of Zagreb School of Medicine, Zagreb, Croatia, 4Patient Research Partner, Amsterdam, Netherlands, 5Leiden University Medical Center and Zuyderland Medical Centre, Leiden, Netherlands, 6ANMAR Young Patient Advocate, Avellino, Italy, 7Patient Research Partner, Brussels, Belgium, 8Sorbonne Université and Hôpital Pitié-Salpêtrière, Paris, France, 9Cyprus League Against Rheumatism, Nicosia, Cyprus, 10King's College London, London, United Kingdom, 11University of Leeds, Leeds, United Kingdom, 12Österreichische Rheumaliga, Bregenz, Austria

    Background/Purpose: Although patient-reported outcome measures (PROMs) are extensively used in clinical practice and research, it is unclear whether the most commonly used instruments adequately cover…
  • Abstract Number: 1153 • 2019 ACR/ARP Annual Meeting

    Double Trouble: Utility of Serial TB Screening in a Rheumatology Clinic Serving a Foreign-Born Population

    Alice Fike1, Yanira Ruiz-Perdomo 1 and James Katz 1, 1NIAMS, BETHESDA, MD

    Background/Purpose: The potential for reactivation of tuberculosis (TB) in patients treated with anti-TNF or other immunosuppressive agents has been well described.  Interferon-gamma release assays (IGRA)…
  • Abstract Number: 1327 • 2019 ACR/ARP Annual Meeting

    The Novel, Intra-articular CLK/DYRK1A Inhibitor Lorecivivint (LOR; SM04690), Which Modulates the Wnt Pathway, Improved Responder Outcomes in Subjects with Knee Osteoarthritis: A Post Hoc Analysis from a Phase 2b Trial

    Yusuf Yazici1, Sarah Kennedy 2, Chris Swearingen 2 and Jeyanesh Tambiah 2, 1Samumed, LLC, San Diego, CA, 2Samumed, LLC, San Diego

    Background/Purpose: Lorecivivint (LOR, SM04690) is a small-molecule, intra-articular (IA) CLK/DYRK1A inhibitor which modulates the Wnt pathway and has demonstrated beneficial effects on patient-reported outcomes (PROs)…
  • Abstract Number: 2360 • 2018 ACR/ARHP Annual Meeting

    Perceptions of Patients with Rheumatoid Arthritis about Self-Assessment of Disease Activity after Watching an Educational Video: Qualitative Pilot Results from the Auto-DAS in Middle Eastern Arab Countries Study

    Nelly Ziade1, Sahar Saad2, Manal al Mashaleh3, Lina el Kibbi4, Bassel el Zorkany5, Humeira Badsha6, Ghita Harifi6, Amani Daher7, Nelly Salloum8, Basel Masri9 and Thurayya Arayssi10, 1Rheumatology, Saint-Joseph University, Beirut, Lebanon, 2Rheumatology, King Hamad University Hospital, Bahrain, Bahrain, 3Rheumatology, King Hussein Medical Center, Royal Medical Services, Amman, Jordan, 4Rheumatology, Specialized Medical Center, Riyadh, Saudi Arabia, 5Rheumatology, Cairo University, Cairo, Egypt, 6Dr. Humeira Badsha Medical Center, Dubai, United Arab Emirates, 7Medicine, Saint-Joseph University, Beirut, Lebanon, 8Registered Nurse, Beirut, Lebanon, 9Rheumatology, Jordan Hospital, Amman, Jordan, 10Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar

    Background/Purpose: Empowering RA patients through education is linked to improved adherence, treatment decisions and speeding up the assessment process during consultation. The purpose of the…
  • Abstract Number: 2369 • 2018 ACR/ARHP Annual Meeting

    Patients Preference Goes to MTX Autoinjectors over Prefilled Syringes: Results from a Phase III Trial

    Alain Saraux1, Christophe Hudry2, Elena Zinovieva3, Agnès Courbeyrette4 and Hélène Herman-Demars3, 1Rheumatology, CHU Brest, Brest, France, 2AP-HP Hôpital Cochin, Paris, France, 3Medical Department Nordic Pharma, Paris, France, 4Medical Departement, Nordic Pharma, Paris, France

    Background/Purpose: The offer of injectable MTX worldwide expanded during past few years with different types of enhanced devices such as prefilled syringes and autoinjector pens.…
  • Abstract Number: 2470 • 2018 ACR/ARHP Annual Meeting

    The Impact of Frailty on Changes in Physical Function Among Adults with Rheumatoid Arthritis

    James Andrews1, Laura Trupin2, Catherine Hough1, Edward H. Yelin3 and Patricia Katz2, 1Medicine, University of Washington, Seattle, WA, 2University of California San Francisco, San Francisco, CA, 3Medicine/Rheumatology, University of California San Francisco, San Francisco, CA

    Background/Purpose: Frailty is a state of excess vulnerability to stressors and is associated with increased risk of poor health outcomes including physical disability. Frailty and…
  • Abstract Number: 2577 • 2018 ACR/ARHP Annual Meeting

    Long-Term Effect of Ixekizumab on Patient-Reported Outcomes in Patients with Psa and Inadequate Response to TNF Inhibitors: 2-Year Follow-up from a Phase 3 Study

    Anthony Turkiewicz1, Amanda M. Gellett2, Lisa Kerr2, Julie Birt2 and Jordi Gratacos3, 1Rheumatology Associates, Birmingham, AL, 2Eli Lilly and Company, Indianapolis, IN, 3Rheumatology, Hospital Parc Taulí, Sabadell - Barcelona, Spain

    Background/Purpose: PsA is a chronic and complex inflammatory disease with both articular and extra-articular symptoms, including joint pain, enthesitis, dactylitis, fatigue, and skin and nail…
  • Abstract Number: 326 • 2018 ACR/ARHP Annual Meeting

    Implementation of a Treat-to-Target Quality Improvement Program for Rheumatoid Arthritis Management Using Real-Time Patient Reported Outcome Measures

    Malka Forman1, Cianna Leatherwood2, Chang Xu1, Eunji Ko1, Bing Lu3, Maura D. Iversen4, Daniel Solomon2 and Sonali Desai2, 1Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 3Division of Rheumatology, Immunology and Allergy, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, 4Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Changing clinical practice patterns and incorporation patient-reported outcome measures (PROMs) for disease activity assessment into routine workflow is challenging. We sought to integrate a…
  • Abstract Number: 2590 • 2018 ACR/ARHP Annual Meeting

    Descriptive Comparisons of the Impact of Apremilast and Methotrexate Monotherapy in Patients with Oligoarticular Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry

    Alexis Ogdie1, Mei Liu2, Meghan Glynn2, Kelechi Emeanuru2, Leslie R Harrold3, Sven Richter4, Benoit Guerette4 and Philip J. Mease5, 1University of Pennsylvania, Philadelphia, PA, 2Corrona, LLC, Waltham, MA, 3University of Massachusetts Medical School, Worcester, MA, 4Celgene Corporation, Summit, NJ, 5Swedish Medical Center and University of Washington School of Medicine, Seattle, WA

    Background/Purpose: The effectiveness of therapies has rarely been studied in the subpopulation of patients with oligoarticular psoriatic arthritis (PsA). The objective of this study was…
  • Abstract Number: 408 • 2018 ACR/ARHP Annual Meeting

    State or Trait: Pain Catastrophizing and Widespread Pain Following TKR and Their Associations with Pain Relief

    Emma Lape1, Faith Selzer1,2, Jamie E. Collins3,4, Elena Losina1,4 and Jeffrey N. Katz1,4, 1Orthopedic Surgery, Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Department of Orthopedic Surgery, Harvard Medical School, Boston, MA, 3Department of Orthopedic Surgery, Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 4Harvard Medical School, Boston, MA

    Background/Purpose: Pain catastrophizing and widespread pain (WP) —constructs reflecting cognitive processes during the pain experience—predict disability, pain chronicity/severity, and lower quality of life in a…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology